Health and Medicine

Study to explore optimal daily aspirin dose for heart health

The Vanderbilt-based Mid-South Clinical Data Research Network (CDRN) is among seven CDRNs that will collaboratively mount a three-year, $14 million randomized clinical trial to determine the best daily dose of aspirin for preventing heart attacks and strokes among people living with heart disease.

Preventing early pregnancy complications

The enzyme alkaline phosphatase may provide a new therapeutic option for women at high risk of pregnancy complications due to bacterial toxin exposure.

Tools for exploring ‘omics’ data

The NetGestalt computing portal integrates vast amounts of data to aid users in finding biologically and clinically relevant information.

Boosting cell-based heart repair

A metabolic change in adult stem cells makes them less “fit” for regenerative heart therapies, suggesting that strategies to prevent this response may boost the therapeutic usefulness of the cells.

Jansen’s cancer research efforts garner recognition

Valerie Malyvanh Jansen, M.D., Ph.D., a third-year medical oncology fellow, recently received several national awards and grants, as well as a Vanderbilt-Ingram Cancer Center fellowship, in recognition of her translational cancer research.

Insights on lysosomal storage diseases

A novel mechanism could point to new therapies for a group of inherited diseases that share pathological features.

1 121 122 123 124 125 197